Effects of modification of amino groups with poly(Ethylene Glycol) on a recombinant uricase from Bacillus fastidiosus

Bioscience, Biotechnology and Biochemistry

Volumn 74, Issue 6, 2010, Pages 1298-1301

  Zhang, Chun ^a   Yang, Xiaolan ^a   Feng, Juan ^a   Yuan, Yonghua ^a   Li, Xiang ^a   Bu, Youquan ^a   Xiu, Yanling ^a   Yuan, Huidong ^a   Liao, Fei ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Hyperuricemia; Mer mo stability; PEG modification; Uuricase

Indexed keywords

AMINO GROUP; COMMON CATION; HYPERURICEMIA; IN-VIVO; REACTION TEMPERATURE; RESIDUAL ACTIVITY; URICASE;

BACTERIOLOGY; ETHYLENE; ETHYLENE GLYCOL; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; RADIOACTIVITY;

PH EFFECTS;

MACROGOL DERIVATIVE; RECOMBINANT PROTEIN; URATE OXIDASE;

ANIMAL; ARTICLE; BACILLUS; BLOOD; CHEMISTRY; ENZYME ACTIVATION; ENZYME STABILITY; ENZYMOLOGY; HALF LIFE TIME; MALE; METABOLISM; PH; RAT; STRUCTURE ACTIVITY RELATION; TEMPERATURE;

ANIMALS; BACILLUS; ENZYME ACTIVATION; ENZYME STABILITY; HALF-LIFE; HYDROGEN-ION CONCENTRATION; MALE; POLYETHYLENE GLYCOLS; RATS; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TEMPERATURE; URATE OXIDASE;

BACILLUS FASTIDIOSUS; RATTUS;

EID: 77953979420     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.100080     Document Type: Article

References (30)

1. Hande KR. Perini F. Pullcrman GJ. and Elm R. Clin Chem., 25, 1492-1494 (1979).
2. Kang DH and Nakagawa T, Semin. Nephrol., 25,43-49 (2005).
3. Davidson MB, Thakkar S, Hix JK, Bhandarkar ND, Wong A, and Schrcibcr Ml, Am. J. Med., 116, 546-554 (2004).
4. Feig DI, Kang DH, and Johnson RJ, N. Engl. J. Med., 359. 1811-1821 (2008).
5. Bandukwala F, Huang M, Zaluman JS, Nash MM. and Prasad GV, Am. J. Cardiol., 103, 867-871 (2009).
6. Jeha S. Kanlarjian H, Irwin D, Shen V, Shcnoy S, Blaney S, Camilla B, and Pui CH, Leukemia, 19, 34-38 (2005).
7. Biggs K and Scheinfeld N, Curr. Opin Invest. Drugs, 9, 422- 429 (2008).
8. Sherman MR. Salter MOP. and Perez-Ruiz F, Adv. Dnig Deliv. Rev., 60, 59-68(2008).
9. Chohan S and Becker MA, Curr. Opin. Rheumatol., 21, 143- 149 (2009).
10. Ahuehowski A, McCoy JR. Palczuk NC, van Es T, and Davis FF, J. Biol. Chem., 252, 3582-3586 (1977).
11. Delgado C, Francis GE, Fisher D. Crit. Rev. Titer. Drug Carrier Syst 9, 249-304 (1992).
12. Harris JM. Martin NE. and Modi M. Clin. Pluirmacokinet., 40, 539-551 (2001).
13. Veronese FM and Mcro A, BioDrugs, 22, 315-329 (2008).
14. Caliceti P, Schiavon O, and Veronese FM. Bioconjug. Chem, 10, 638-646 (1999).
15. Schiavon O. Caliceti P. Fcrruli P. and Veronese FM. Farmaco, 55, 264-269 (2000).
16. Bomalaski JS, Holtsberg FW, Ensor CM, and Clark MA, J Rheumatol., 29, 1942-1949 (2002).
17. Sundy JS, Ganson NJ, Kelly SJ, Scarlett EL, Rehrig CD, Huang W, and Hershtield MS. Arthritis Rheum.. 56, 1021-1028 (2007).
18. Yue CS, Huang W, Alton M, Maroli AN, Waltrip RW, Wright D, and Marco MD, J. Clin. Pliarmacol., 48, 708-718 (2008).
19. Liu Z, Lu D, Li J, Chen W, and Liu Z, Phys. Chem. Chem. Phys., 11, 333-340 (2009).
20. Frklovich I, J. Biol. Cliem., 240, 2491-2494 (1965).
21. Sedor FA and Sander EG, Biochem Biophys. Res. Commuti, 75, 406-413 (1977).
22. Liao F, Zhu XY, Wang YM, and Zuo YP, J. Biochem Biophys. Methods, 62, 13-24 (2005).
23. Kahn K and Tipton PA, Biochem, 36,4731-4738 (1997).
24. Zhao YS, Zhao LN, Yang GQ, Tao J, Bu YQ, and Liao F, Biotechnol. Appl. Biochem, 45, 75-80 (2006).
25. Liao F, Zhao YS, Zhao LN, Tao J, Zhu XY, and Liu L, J. Zhejiang Univ. Sci. B, 7, 497-502 (2006).
26. Zhao YS, Yang XL, Li XY, Bu YQ, Deng P, Zhang C, Feng J, Xic YL, Zhu S, Yuan HD, Yu MA, and Liao F, Biosci. Biotechnol. Biochem., 43, 2141-2144 (2009).
27. Kynclova E, Eisner E. Kopf A, Hawa G, Schalkhammer T, and Pinner F, J. Mol. Recognit., 9, 644-651 (1996).
28. Bradford MM, Anal Biochem, 72, 248-254 (1976).
29. Snyder SL and Sobocinski PZ, Anal Biochem, 64, 284-288 (1975).
30. Seekr JS and Dejcan A, Nat. Rev. Mol. Cell Biol., 4, 696-699 (2003).